Member Info for panman

Yes they will slacker. They'll likely follow the path of everyone else that's using it. ie- PSA first. If that comes up with a positive then PSE to save on un necessary autopsies and other expensive exploratory investigations and save themselves money and the patient wasted time and treatment.

Would expect the price for the NHS to be a lot cheaper too for bulk if nothing else.

PSE test seem to be building its base here and the U.S. May have fairly good revenue stream soon if not already..

https://integratedcarejournal.com/new-prostate-cancer-test-cuts-biopsies-50-us-real-world-use

Good to have BUPA and their 4M customers here in UK too. They just need to keep building on the customer base.

https://www.pharmiweb.com/press-release/2025-03-13/bupa-uk-insurance-to-cover-oxford-biodynamics-episwitch-pse-prostate-cancer-test

It was also compared to Norilsk due to the potential size of the resource there. KoBold's technical teams may have started it when 80M was still Bluejay..

"These seven priority targets exhibit spatial characteristics indicative of potential deposits on a scale comparable to renowned mining operations such as Norilsk, Voisey's Bay, or Jinchuan"

https://markets.ft.com/data/announce/detail?dockey=1323-16445433-7R3T4T0TF5360EE693SFQKJ7DN

Likely because "we're" not producing the stuff. M3 helium is and that's a different co? Once that's sorted expecting things to change sp wise but with the big warning on every RNS and the amount of delays we've had fair enough we're stuck in the mud for now imo.

Be good to get an update on how the 2 drills are going too. News can't be far away now?

Interesting that they think "long covid" maybe chronic fatigue syndrome itself.. (from the vid)

https://www.msn.com/en-ca/health/other/breakthrough-as-scientists-develop-first-ever-test-for-debilitating-condition/ar-AA1O2IXy

Getting a lot of media attention. Also sounds like Prof Ponting maybe a tad jealous?..

"Prof Chris Ponting, from the University of Edinburgh, who wasn't involved in the research"

Thanks TalkingSense good to get some idea of the no's out there. Realise its not investment advice but appreciate the effort all the same.

Quite apart from the fact that this is only one play in my porti and its only been 24hrs plenty of others are tanking also but thanks for the advice all the same, lol

Thinking about it not sure I agree volume is the only way to go re these tests.

Agree that if its picked up by the NHS as a test for all men in the UK it should come down considerably but then you're talking so many tests/year everything changes but current no's I have are 63,000 men in the UK diagnosed with prostrate cancer every year.

Should imagine the no's tested are higher due to the negative results not known but jut working with the 63K if all of them were tested at £100 /pop that would raise gross revenue of £6.3M but for a lot of work.

If they pick up 10% of that no. at £900 a time then they still take in £5.6M but with a lot less testing.

USA and rest of world may be different when they get there but til they get the NHS and major no's to be tested maybe dear is the way to go in the UK at least

https://prostatecanceruk.org/for-health-professionals/data-and-evidence

Bought just a few today on the back of the CCS and the drill so be good if its BLOE's time to shine.

Yes I was offered that test. He said sit on my finger and spin but I didn't trust him so declined.

Quite a pricey test. Not going to have to do a lot to get the revenue flowing. Think they may need to give the NHS a discount for volume sales though..

https://health.goodbodyclinic.com/product/episwitch-pse-advanced-blood-test

Got the above ling through their X page.

And revenue on its way...

https://x.com/AndrewScottTV/status/1975095199115497728

Re PAL news today..

Summary by AI BETAClose X

Manx Financial Group's subsidiary, Payment Assist Limited (PAL), has extended its consultancy agreement with Neil Jeffery until August 2030 to support international growth. The agreement allows for a cash payment of up to £6 million, contingent on revenue targets and performance milestones. This extension aims to provide stability for PAL's expansion of "Buy-Now-Pay-Later" products into Ireland, mainland Europe, and the Middle East. PAL anticipates increasing its annual advances by 50% from £147 million in 2023 to £220 million in 2025, with Jeffery's expertise being crucial to this growth.

Good to hear the pi segment was well taken up. See where the sp heads to with the placing out the way and funds in the bank for production now.

See PAL is being expanded greatly and moving into the Middle East now too . Hopefully will be good for Fiinu's revenue prospects down the line too.

https://www.investegate.co.uk/announcement/rns/manx-financial-group--mfx/consultancy-agreement-for-pal-s-growth-/9151298

Sounds like he's right about the PSA screening. Its not definitive and leads to more invasive testing that may be unnecessary.

PSE however is 94% accurate as stated in the sciencedaily link so doesn't make a lot of sense to lump them all together?

They did extremely well if they really did manage to arrange this placing whilst the sp was .3p as it was only there for a couple of days in 2 spikes and that was mid Sept? The 50 day VWAP never rose above .25p and spent most of the last 5-6 months stuck around the .21 - .24 range so would have thought that a much safer level for Institutions to want to partake at . They don't like being spiked either imo.

Maybe but still to be seen if the markets correct in pricing in an RNS announcing a further delay in Nov.

Gold looks good too imho. They've posted pics on X. Looking forward to their processing results as they come in..

https://x.com/Share_Talk/status/1974012555820507255